Nutriband Inc. announced that the United States Patent and Trademark Office (USPTO) issued patent number 12,318,492 on June 3, 2025. The patent is entitled 'Abuse and Misuse Deterrent Transdermal Systems.'
The issuance of this patent further expands Nutriband’s intellectual property protection in the United States for its proprietary AVERSA™ abuse deterrent technology. This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential.
The AVERSA™ abuse deterrent technology is now protected by a broad international intellectual property portfolio with patents issued in 46 countries. This strengthens the company's competitive position for its lead product, AVERSA™ Fentanyl, which has the potential to become the first abuse deterrent pain patch on the market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.